Red blood cell alloimmunization after bone-allograft transplantationL. PRINZEN
Hele tekst
GERELATEERDE DOCUMENTEN
Chapter 2 Rhesus hemolytic disease of the newborn: postnatal management, associated morbidity and long-term outcome. Semin Fetal Neonatal Med
During this study period several study projects on management, complications and outcome in hemolytic disease of the newborn (HDN) due to red cell alloimmunization were
In our center term neonates with RHDN are treated with transfusions of red blood cells when hemoglobin levels fall below 8.0 g/dL (5.0 mmol/L) or below 9.6 g/dL
We recorded the following obstetric and neonatal data: fetal hemoglobin (Hb) concentration and gestational age at first IUT, number of IUTs, gestational age at birth, birth weight,
Umbilical venous catheterization was required in this case because an ET was deemed necessary to reduce the elevated bilirubin levels and the risk of
(classified according to Bell’s criteria 20 ), proven sepsis (clinical and/or biochemical signs of infection with a positive blood culture), suspected sepsis (clinical
6,8-10 Data on the incidence and severity of cholestasis in neonates with red cell alloimmune hemolytic disease is scarce, and little is known about pathogenesis, risk
We recorded the following obstetric and neonatal data: type of red cell alloimmunization, number of IUTs, presence of fetal hydrops, fetal platelet count before each IUT, number of